Moreover, Trp treatment in animal models of IBD such as DSS-induced colitis attenuates the symptoms and severity and decreases the expression of pro-inflammatory cytokines by the transcription factor aryl hydrocarbon receptor (Ahr) activation involved in the regulation of inflammation and immunity [73,74,75]. Here, AHR is linked to inflammatory bowel disease.